Please assess the completion status of the following clinical trial:

Trial Title: Convalescent Plasma in COVID-19 Elderly Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Elderly patients (\> 65 years old) with SARS-CoV-2 RT-PCR positivity on nasal swab or score higher than 5 with the following characteristics:~  * New onset or worsening of recently onset respiratory symptoms (\<10 days);~ * Radiological imaging (CT, X-ray, Ultrasound) of bilateral pulmonary opacities not fully explained by pleural effusion, pulmonary or lobar atelectasis, pulmonary nodules;~ * Respiratory failure (SpO2 \<95%) not fully explained by heart failure or water overload (after excluding hydrostatic causes of edema in the absence of risk factors by objective assessment, for example ultrasound);~* Patients who have signed informed consent.~Exclusion Criteria:~* New onset or worsening of respiratory symptoms that began more than 10 days ago;~* Patients with proven hypersensitivity or allergic reaction to plasma, blood products or immunoglobulins;~* Manifest desire not to be included in the research protocol.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- convalescent plasma (Type: EXPERIMENTAL): Cohort of elderly patients treated with convalescent plasma

Based on this trial design, predict the completion outcome and termination type (if applicable).